From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

Several large Massachusetts employers have filed annual reports with federal securities regulators that are notable for ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Boston biotech Kojin Therapeutics is closing its doors, citing four funding challenges and a few valuable lessons learned.  ...

Sales of an Alzheimer’s disease treatment were better than expected, but that and a quarterly beat wasn’t enough to offset ...

Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...

Analysts expect the Cambridge, Massachusetts-based company to report quarterly earnings at $3.36 per share, up from $2.95 per ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

CVS Health reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business saw higher medical costs. The company also issued a full-year 2025 adjusted profit ...

(Petra) his majesty King Abdullah II on Monday met with CEOs of companies and heads of universities and higher education institutions in Boston, Massachusetts, to discuss means of building and ...

Gov. Maura Healey rolled out the red carpet Monday to welcome King Abdullah II of Jordan before the two sat down for talks about strengthening trade relations between the Bay State and the middle ...